Multi-omic-based classification for identifying optimal neoadjuvant treatment strategies for high-risk early-stage breast cancer. - Ji F; Chen X; Yang C; Zhang L; Yang M; Li J; Gao H; Zhu T; Cheng M; Chen Y; Peng H; Wang J; et al. (Science China. Life sciences, 2025)